Apolipoprotein B (APOB) Antibody

195€ (20 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Apolipoprotein B (APOB) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx001189
tested applications
ELISA, WB, IF/ICC
Description
APOB Antibody is a Rabbit Polyclonal antibody against APOB. APOB, also named as Apo B-48 and Apo B-100, is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). APOB functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor. Defects in APOB are a cause of familial hypobetalipoproteinemia (FHBL). Defects in APOB are a cause of familial ligand-defective apolipoprotein B-100 (FDB). Defects in APOB associated with defects in other genes (polygenic) can contribute to hypocholesterolemia. The antibody is specific to APOB.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Apolipoprotein B (APOB) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | ELISA: 1 µg/ml, WB: 1/500 - 1/1000, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Purified by affinity chromatography. |
Size 1 | 20 µl |
Size 2 | 100 µl |
Size 3 | 2 × 100 µl |
Form | Liquid |
Tested Applications | ELISA, WB, IF/ICC |
Buffer | PBS, pH 7.3, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | P04114 |
Gene ID | 338 |
NCBI Accession | NP_000375.3 |
Alias | APOB, FLDB, LDLCQ4, apoB-100,apolipoprotein B, FCHL2 |
Background | Antibody anti-APOB |
Status | RUO |
Note | Concentration: > 0.2 mg/ml - |
Descripción
APOB is a major structural protein of low-density lipoproteins (LDL), very-low-density lipoproteins (VLDL), and chylomicrons, which are essential for lipid transport and metabolism in the body It exists in two primary isoforms: APOB-100, produced in the liver, and APOB-48, synthesized in the intestine APOB-100 is critical for the assembly and secretion of VLDL and LDL particles, facilitating the transport of cholesterol and triglycerides to peripheral tissues via binding to the LDL receptor (LDLR) Mutations or overexpression of APOB contribute to familial hypercholesterolemia and other dyslipidemias, leading to elevated LDL cholesterol levels and increased risk of atherosclerosis and cardiovascular diseases APOB-48, on the other hand, plays a key role in chylomicron formation and dietary fat absorption Genetic variations in the APOB gene have been linked to metabolic disorders, including obesity, diabetes, and fatty liver disease APOB levels serve as a marker of cardiovascular risk, with elevated concentrations indicating higher susceptibility to coronary artery disease Therapies targeting APOB, such as antisense oligonucleotides or LDL-lowering drugs like statins, have shown significant success in reducing cardiovascular events APOB remains a key focus in lipid biology due to its central role in lipid transport and cardiovascular health
Related Products

Bovine ApoB100 (Apolipoprotein B100) ELISA Kit
Ver Producto
Human ApoB100 (Apolipoprotein B100) ELISA Kit
Ver Producto